M.J. Leonard Reyno's most recent trade in C4 Therapeutics Inc was a trade of 130,600 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 14, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
C4 Therapeutics Inc | Leonard M.J. Reyno | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2025 | 130,600 | 130,600 | - | - | Stock Option (Right to Buy) | |
C4 Therapeutics Inc | Leonard M.J. Reyno | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2025 | 87,100 | 178,909 | - | 0 | Common Stock | |
C4 Therapeutics Inc | Leonard M.J. Reyno | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.18 per share. | 14 Feb 2025 | 5,145 | 173,764 | - | 3.2 | 16,361 | Common Stock |
C4 Therapeutics Inc | Leonard M.J. Reyno | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.00 per share. | 10 Jul 2024 | 6,191 | 91,809 | - | 5 | 30,955 | Common Stock |
C4 Therapeutics Inc | M.J. Leonard Reyno | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 165,300 | 165,300 | - | - | Stock Option (Right to Buy) | |
C4 Therapeutics Inc | Reyno Leonard M.J. | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 36,700 | 98,000 | - | 0 | Common Stock | |
C4 Therapeutics Inc | Leonard M.J. Reyno | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jul 2023 | 276,000 | 276,000 | - | - | Stock Option (Right to Buy) | |
C4 Therapeutics Inc | Leonard M.J. Reyno | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jul 2023 | 61,300 | 61,300 | - | 0 | Common Stock |